TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TRDA

Entrada Therapeutics Inc

Healthcare · Biotechnology · —

6.20$ -1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TRDA
Line item 2019 2020 2021 2022 2023 2024 2025
0.00 0.00 0.00 0.81 3.90 5.40 0.61
0.10 0.01 0.04 0.06 3.02 0.10 0.10
-0.10 -0.01 -0.04 -0.06 3.90 5.40 0.52
7.84 0.68 1.15 2.13 3.02 3.21 3.44
3.44 0.18 0.49 0.98 0.98 0.99 0.99
11.28 0.84 1.64 3.11 4.00 4.20 4.29
-11.28 -0.85 -1.64 -3.11 -0.10 1.21 -3.77
0.00 0.00 0.00 0.08 – – –
-4.87 -0.85 -1.64 -3.02 0.36 1.70 -3.45
-0.43 0.00 -0.03 -0.23 0.57 0.02 0.02
-4.44 -0.85 -1.60 -2.79 -0.20 1.68 -3.47
-11.18 -0.84 -1.60 -3.05 0.45 1.80 -3.44

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?